The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo
Open accessAbstract
Several people with Parkinson's disease have been treated with intrastriatal grafts of fetal dopaminergic neurons. Following autopsy, 10-22 years after surgery, some of the grafted neurons contained Lewy bodies similar to those observed in the host brain. Numerous studies have attempted to explain these findings in cell and animal models. In cell culture, α-synuclein has been found to transfer from one cell to another, via mechanisms that include exosomal transport and endocytosis, and in certain cases seed aggregation in the recipient cell. In animal models, transfer of α-synuclein from host brain cells to grafted neurons has been shown, but the reported frequency of the event has been relatively low and little is known about the underlying mechanisms as well as the fate of the transferred α-synuclein. We now demonstrate frequent transfer of α-synuclein from a rat brain engineered to overexpress human α-synuclein to grafted dopaminergic neurons. Further, we show that this model can be used to explore mechanisms underlying cell-to-cell transfer of α-synuclein. Thus, we present evidence both for the involvement of endocytosis in α-synuclein uptake in vivo, and for seeding of aggregation of endogenous α-synuclein in the recipient neuron by the transferred α-synuclein. Finally, we show that, at least in a subset of the studied cells, the transmitted α-synuclein is sensitive to proteinase K. Our new model system could be used to test compounds that inhibit cell-to-cell transfer of α-synuclein and therefore might retard progression of Parkinson neuropathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Others have shown in vitro and in vivo that alpha-synuclein is transmitted via endocytosis to neighboring neurons (Angot et al., 2012;Desplats et al., 2009).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Angot et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Self-citationLewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Cited by
Sorted by citations
Items 101–200 of 269
Mitochondria and Antibiotics: For Good or for Evil?
Suarez-Rivero, J. M., Pastor‐Maldonado, C. J., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Talaverón-Rey, M., Suárez-Carrillo, A., Munuera-Cabeza, M., & Sánchez-Alcázar, J. A. (2021) · Biomolecules · doi:10.3390/biom11071050 · Cited by 52
Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy
Choi, I., Heaton, G. R., Lee, Y.-K., & Yue, Z. (2022) · Science Advances · doi:10.1126/sciadv.abn1298 · Cited by 54
Neuropathology in transplants in Parkinson's disease
Brundin, P., & Kordower, J. H. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59575-1.00010-7 · Cited by 55
Self-citationMalfertheiner, K., Stefanova, N., & Heras-Garvin, A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.737195 · Cited by 46
Alpha-synuclein-based models of Parkinson's disease
Dehay, B., & Fernagut, P. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2016.04.003 · Cited by 55
Gut Microbiota Approach—A New Strategy to Treat Parkinson’s Disease
Liu, J., Xu, F., Nie, Z., & Shao, L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.570658 · Cited by 52
Pukaß, K., & Richter‐Landsberg, C. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0154-x · Cited by 48
Ko, W. K. D., & Bézard, E. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.07.020 · Cited by 48
Synucleins: Are they two‐edged swords?
Surguchov, A. P. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23149 · Cited by 46
Bayati, A., & McPherson, P. S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107742 · Cited by 47
Svarcbahs, R., Julku, U. H., & Myöhänen, T. T. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2309-16.2016 · Cited by 49
What Is the Evidence that Parkinson’s Disease Is a Prion Disorder, Which Originates in the Gut?
Kujawska, M., & Jodynis‐Liebert, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113573 · Cited by 48
Bates, C. A., & Zheng, W. (2014) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-11-17 · Cited by 47
Alpha-synuclein and the prion hypothesis in Parkinson's disease
Melki, R. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.08.002 · Cited by 52
Novel animal model defines genetic contributions for neuron-to-neuron transfer of α-synuclein
Tyson, T., Senchuk, M. M., Cooper, J. F., George, S., Raamsdonk, J. M. V., & Brundin, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-07383-6 · Cited by 45
Self-citationSvarcbahs, R., Julku, U. H., Kilpeläinen, T. P., Kyyrö, M., Jäntti, M. H., & Myöhänen, T. T. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.013 · Cited by 43
Cryo-EM structure of alpha-synuclein fibrils amplified by PMCA from PD and MSA patient brainsPreprint
Burger, D., Fenyi, A., Bousset, L., Stahlberg, H., & Melki, R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.08.451588 · Cited by 43
α-Synuclein and huntingtin exon 1 amyloid fibrils bind laterally to the cellular membrane
Monsellier, É., Bousset, L., & Melki, R. (2016) · Scientific Reports · doi:10.1038/srep19180 · Cited by 43
Small but Mighty—Exosomes, Novel Intercellular Messengers in Neurodegeneration
Kumari, M., & Anji, A. (2022) · Biology · doi:10.3390/biology11030413 · Cited by 41
Towards translational therapies for multiple system atrophy
Kuzdas-Wood, D., Stefanova, N., Jellinger, K. A., Seppi, K., Schlossmacher, M. G., Poewe, W. H., & Wenning, G. K. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.007 · Cited by 39
CSF biomarkers in neurodegenerative and vascular dementias
Llorens, F., Schmitz, M., Ferrer, I., & Zerr, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.03.003 · Cited by 44
Masnata, M., & Cicchetti, F. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00647 · Cited by 39
Therapeutic strategies in Parkinson's disease: what we have learned from animal models
Valadas, J. S., Vos, M. H., & Verstreken, P. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12577 · Cited by 44
Grudina, C., Kouroupi, G., Nonaka, T., Hasegawa, M., Matsas, R., & Zurzolo, C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104609 · Cited by 39
Angelopoulou, E., Paudel, Y. N., Villa, C., Shaikh, M. F., & Piperi, C. (2020) · Biology · doi:10.3390/biology9040086 · Cited by 40
Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
Kaufman, S. K., & Diamond, M. I. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0196-3 · Cited by 40
Distinct higher-order α-synuclein oligomers induce intracellular aggregation
Illes‐Toth, E., Ramos, M. R., Cappai, R., Dalton, C., & Smith, D. P. (2015) · Biochemical Journal · doi:10.1042/bj20150159 · Cited by 37
Tamburrino, A., Churchill, M. J., Wan, O. W., Colino‐Sanguino, Y., Ippolito, R., Bergstrand, S., Wolf, D. A., Herz, N. J., Sconce, M. D., Björklund, A., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0263-6 · Cited by 41
Self-citationLeeboonngam, T., Pramong, R., Sae‐ung, K., Govitrapong, P., & Phansuwan‐Pujito, P. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12456 · Cited by 36
Promising Targets for the Treatment of Neurodegenerative Diseases
Haeberlein, S. B., & Harris, T. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.195 · Cited by 35
A Cleaning Crew: The Pursuit of Autophagy in Parkinson’s Disease
Parekh, P., Sharma, N., Gadepalli, A., Shahane, A., Sharma, M., & Khairnar, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00244 · Cited by 34
α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox
Simon, C. A., Soga, T., Okano, H. J., & Parhar, I. S. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00709-y · Cited by 35
The Role of Glial Mitochondria in α-Synuclein Toxicity
Jeon, Y., Kwon, Y., Jo, M., Lee, S., Kim, S., & Kim, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.548283 · Cited by 31
Fenyi, A., Duyckaerts, C. J., Bousset, L., Braak, H., Tredici, K. D., Melki, R., & on behalf of the Brainbank Neuro-CEB Neuropathology Network (2021) · Cells · doi:10.3390/cells10010139 · Cited by 31
Is Parkinson’s Disease Truly a Prion-Like Disorder? An Appraisal of Current Evidence
Chauhan, A., & Jeans, A. F. (2015) · Neurology Research International · doi:10.1155/2015/345285 · Cited by 34
Neuropathology of Parkinson’s Disease
Jellinger, K. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_2 · Cited by 31
Protein aggregation and prionopathies
Renner, M. L., & Melki, R. (2014) · Pathologie Biologie · doi:10.1016/j.patbio.2014.01.003 · Cited by 31
Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments
Chelpin, M. V. E., & Vorup‐Jensen, T. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12542 · Cited by 27
α-Synuclein pathology and mitochondrial dysfunction: Toxic partners in Parkinson's disease
Mingo, Y. B., Galvis, M. L. E., & Henderson, M. X. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106889 · Cited by 30
Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases
McAlary, L., Plotkin, S. S., & Cashman, N. R. (2019) · CNS Drugs · doi:10.1007/s40263-019-00657-9 · Cited by 26
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
Fouka, M., Mavroeidi, P., Tsaka, G., & Xilouri, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559791 · Cited by 27
Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism
Fernández‐Borges, N., Eraña, H., Elezgarai, S. R., Harrathi, C., Gayosso, M., & Castilla, J. (2013) · International Journal of Cell Biology · doi:10.1155/2013/583498 · Cited by 26
Eraña, H., Venegas, V., Charco, J. M., & Castilla, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.166 · Cited by 26
Chakraborty, R., Dey, S., Sil, P., Paul, S., Bhattacharyya, D., Bhunia, A., Sengupta, J., & Chattopadhyay, K. (2021) · Communications Biology · doi:10.1038/s42003-021-02026-z · Cited by 21
Drobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24
Disease-modifying therapeutic directions for Lewy-Body dementias
Zhang, Q., Kim, Y.-C., & Narayanan, N. S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00293 · Cited by 26
Yeni, Y., Genç, S., Ertuğrul, M. S., Nadaroğlu, H., Gezer, A., Mendĭl, A. S., & Hacımüftüoğlu, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-69324-4 · Cited by 26
Neurodegeneration models in Parkinson’s disease: cellular and molecular paths to neuron death
Álvarez‐Luquín, D. D., González-Fernández, R. R., Torres-Velasco, M. E., Ichikawa-Escamilla, E., Arce-Sillas, A., Martínez‐Martínez, E., Miranda-Narváez, C. L., Rodríguez-Ramírez, J. F., & Adalid-Peralta, L. V. (2025) · Behavioral and Brain Functions · doi:10.1186/s12993-025-00279-w · Cited by 29
Magalingam, K. B., Radhakrishnan, A. K., Somanath, S. D., Md, S., & Haleagrahara, N. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05925-2 · Cited by 23
Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence
Henriques, A., Rouvière, L., Giorla, E., Farrugia, C., Waly, B. E., Poindron, P., & Callizot, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179864 · Cited by 24
Myöhänen, T. T., Norrbacka, S., & Savolainen, M. H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.11.008 · Cited by 22
The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson's Disease
Yang, R., Gao, G., & Yang, H. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.861035 · Cited by 24
Schorova, L., Bedard, N., Khayachi, A., Ho, H.-H., Bolivar-Pedroso, J., Huynh, J., Piccirelli, M., Wang, Y., Plourde, M., Luo, W., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00601-1 · Cited by 20
Koh, Y. H., Tan, L. Y., & Ng, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00413 · Cited by 20
Multiple system atrophy: experimental models and reality
Overk, C., Rockenstein, E. M., Valera, E., Stefanova, N., Wenning, G. K., & Masliah, E. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1772-0 · Cited by 23
Hadi, F., Akrami, H., Totonchi, M., Barzegar, A., Nabavi, S. M., & Shahpasand, K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15257 · Cited by 22
Animal modeling an oligodendrogliopathy – multiple system atrophy
Bleasel, J. M., Halliday, G. M., & Kim, W. S. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0279-6 · Cited by 19
Liu, W., Zhang, W., Xing, L.-Z., Zhao, Y., Xu, J., Li, R.-J., & Zhang, Y. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117529 · Cited by 20
Victoria, G. S., & Zurzolo, C. (2015) · Virus Research · doi:10.1016/j.virusres.2015.01.019 · Cited by 20
A note on testing hypotheses for stationary processes in the frequency domain
Holger Dette, A., & Hildebrandt, T. (2011) · Journal of Multivariate Analysis · doi:10.1016/j.jmva.2011.07.002 · Cited by 19
Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets
Gambino, C. M., Sasso, B. L., Bivona, G., Agnello, L., & Ciaccio, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191112093034 · Cited by 19
Transport of cargo from periphery to brain by circulating monocytes
Cintron, A. F., Dalal, N. V., Dooyema, J. M., Betarbet, R. S., & Walker, L. C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.06.047 · Cited by 19
Single cell imaging and quantification of TDP-43 and α-synuclein intercellular propagation
Peled, S., Sade, D., Bram, Y., Porat, Z., Kreiser, T., Mimouni, M., Lichtenstein, A., Segal, D., & Gazit, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-00657-z · Cited by 19
Interactions of Gut Endocrine Cells with Epithelium and Neurons
Liddle, R. A. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170044 · Cited by 22
α‐Synuclein Oligomers: A Study in Diversity
van Diggelen, F., Tepper, A. W. J. W., Apetri, M. M., & Otzen, D. E. (2016) · Israel Journal of Chemistry · doi:10.1002/ijch.201600116 · Cited by 18
Uncovering Novel Therapeutic Targets for Parkinson’s Disease
Soni, R., Delvadia, P., Joharapurkar, A. A., & Shah, J. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00084 · Cited by 17
Sauerbeck, A. D., Goldstein, E. Z., Alfredo, A. N., Norenberg, M. D., Marcillo, A. E., & McTigue, D. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-91116-3 · Cited by 17
A role for the proteasome in the turnover of S up35p and in [ PSI +] prion propagation
Kabani, M., Redeker, V., & Melki, R. (2014) · Molecular Microbiology · doi:10.1111/mmi.12572 · Cited by 17
The primary neuronal cells are more resistant than PC12 cells to α-synuclein toxic aggregates
Heravi, M., Dargahi, L., Parsafar, S., Marvian, A. T., Aliakbari, F., & Morshedi, D. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.055 · Cited by 16
HSP90 Co-Chaperone, CacyBP/SIP, Protects α-Synuclein from Aggregation
Bohush, A., & Filipek, A. (2020) · Cells · doi:10.3390/cells9102254 · Cited by 15
Natale, G., Pompili, E., Biagioni, F., Paparelli, S., Lenzi, P., & Fornai, F. (2013) · European Journal of Histochemistry · doi:10.4081/ejh.2013.e5 · Cited by 16
Bendig, J., Frank, A. K., & Reichmann, H. (2024) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2023.36 · Cited by 15
The struggle by Caenorhabditis elegans to maintain proteostasis during aging and disease
Kikis, E. A. (2016) · Biology Direct · doi:10.1186/s13062-016-0161-2 · Cited by 17
Review: The fate of cell grafts for the treatment of H untington's disease: the post‐mortem evidence
Cisbani, G., & Cicchetti, F. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12104 · Cited by 17
The science and ethics of cell-based therapies for Parkinson's disease
Towns, C. R. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.10.012 · Cited by 15
α‐Synuclein Pathology Spreads in a Midbrain–Hindbrain Assembloid Model
Gomez‐Giro, G., Frangenberg, D., Gutiérrez, D. M. V., Žagare, A., Barmpa, K., Antony, P. M. A., Robertson, G., Sabahi‐Kaviani, R., Händler, K., Kruse, N., et al. (2025) · Advanced Science · doi:10.1002/advs.202409040 · Cited by 14
α -Synuclein Trafficking in Parkinson’s Disease: Insights From Fly and Mouse Models
Cheng, J., Lu, Q., Li, S., & Ho, M. S.-C. (2018) · ASN NEURO · doi:10.1177/1759091418812587 · Cited by 14
Cell-free amplification of prions: Where do we stand?
Cazzaniga, F. A., Luca, C. M. G. D., Bistaffa, E., Consonni, A., Legname, G., Giaccone, G., & Moda, F. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.005 · Cited by 14
Veys, L., houcke, J. V., Aerts, J., Pottelberge, S. V., Mahieu, M., Coens, A., Melki, R., Moechars, D., Muynck, L. D., & Groef, L. D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.614587 · Cited by 16
The unique neuropathological vulnerability of the human brain to aging
Ferrer, I. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101916 · Cited by 15
A feature analysis of lower solubility proteins in three eukaryotic systems
Albu, R. F., Chan, G. T., Zhu, M., Wong, E. T. C., Taghizadeh, F., Hu, X., Mehran, A. E., Johnson, J. D., Gsponer, J. A., & Mayor, T. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.10.011 · Cited by 14
Sanjeev, A., Sahu, R. K., & Mattaparthi, V. S. K. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1254119 · Cited by 13
Etiology and Pathogenesis of Parkinson Disease
deSouza, R., & Schapira, A. H. V. (2017) · Neurodegeneration · doi:10.1002/9781118661895.ch5 · Cited by 13
Animal models for prion-like diseases
Fernández‐Borges, N., Eraña, H., Venegas, V., Elezgarai, S. R., Harrathi, C., & Castilla, J. (2015) · Virus Research · doi:10.1016/j.virusres.2015.04.014 · Cited by 13
Experimental colitis drives enteric alpha-synuclein accumulation and Parkinson-like brain pathologyPreprint
Grathwohl, S. A., Quansah, E., Maroof, N., Steiner, J. A., Spycher, L., Benmansour, F., Durán-Pacheco, G., Siebourg‐Polster, J., Oroszlan‐Szovik, K., Remy, H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/505164 · Cited by 13
Self-citationThe role of microglia in the prion-like transmission of protein aggregates in neurodegeneration
Öztürk, M. M., Emgård, J., García‐Revilla, J., Fernández‐Calle, R., Yang, Y., Deierborg, T., & Roos, T. T. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf087 · Cited by 14
Unveiling the significance of synaptic proteins in parkinson's pathogenesis: A review
Soni, R., & Shah, J. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140789 · Cited by 10
Pharmacophore modeling and 3D-QSAR study for the design of novel α-synuclein aggregation inhibitors
Yang, J., Hu, J., Zhang, G., Li, Q., Wen, H., & Tang, Y. (2021) · Journal of Molecular Modeling · doi:10.1007/s00894-021-04881-3 · Cited by 10
La maladie de Parkinson est-elle une maladie à prion ?
Brandel, J., Corbillé, A.-G., Derkinderen, P., & Haı̈k, S. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.10.005 · Cited by 13
Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
Dening, Y., Straßl, T., Ruf, V., Dirscherl, P., Chovsepian, A., Stiévenard, A., Khairnar, A., Schmidt, F., Giesert, F., Herms, J. W., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-25790-2 · Cited by 9
Jewett, M. A. S., Dickson, E., Brolin, K. A., Negrini, M., Jiménez-Ferrer, I., & Swanberg, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00222 · Cited by 10
Moreira, R., Mendonça, L. S., & de Almeida, L. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212288 · Cited by 7
Poortvliet, P. C., O’Maley, K. A., Silburn, P. A., & Mellick, G. D. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00686 · Cited by 7
Sato, H., Kato, T., & Arawaka, S. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8858-7 · Cited by 7
Structural disorder and the loss of RNA homeostasis in aging and neurodegenerative disease
Gray, D. A., & Woulfe, J. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00149 · Cited by 8
Pariary, R., Bhattacharyya, D., & Bhunia, A. (2019) · Gene Reports · doi:10.1016/j.genrep.2019.100423 · Cited by 6
Computational Study on the Role of γ-Synuclein in Inhibiting the α-Synuclein Aggregation
Sanjeev, A., & Mattaparthi, V. S. K. (2018) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524918666181012160439 · Cited by 6
Monsellier, É., Bendifallah, M., Redeker, V., & Melki, R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237328 · Cited by 5
Jellinger, K. A. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1638908 · Cited by 6
Liberski, P. P., & Ironside, J. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-398270-4.00023-9 · Cited by 5
Metadata
- Authors
- Angot, E., Steiner, J. A., Lema Tomé, C. M., Ekström, P., Mattsson, B., Björklund, A., & Brundin, P.
- Affiliations
- Van Andel Institute (US)
- Lund University (SE)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-06-21
- Volume
- 7
- Issue
- 6
- Pages
- e39465
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3380846
- OpenAlex
- W1973113152
- Cited by
- 270
- References
- 45
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 8 · 2023: 8 · 2022: 15 · 2021: 22 · 2020: 30 · 2019: 24 · 2018: 19 · 2017: 28 · 2016: 27 · 2015: 23 · 2014: 23 · 2013: 27 · 2012: 3
- FWCI
- 15.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- Rosenberg Foundation
- Strong
- Lunds Universitet
- Vetenskapsrådet
- Parkinsonfonden
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- alpha-synuclein, cell-to-cell transmission, seeding, Parkinson's disease, intrastriatal transplantation, Lewy bodies, endocytosis, exosomes, proteinase K sensitivity, alpha-synuclein overexpression, alpha-synuclein aggregation, rat model
- MeSH terms
- Animals, Brain, Cell Communication, Cell Survival, Disease Models, Animal, Dopamine, Female, Gene Expression Regulation, Humans, Parkinson Disease, Phosphorylation, Lewy Bodies, Rats, Sprague-Dawley, Endopeptidase K, Rats, alpha-Synuclein, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review